000 | 01108 a2200301 4500 | ||
---|---|---|---|
005 | 20250518030736.0 | ||
264 | 0 | _c20200615 | |
008 | 202006s 0 0 eng d | ||
022 | _a1558-8238 | ||
024 | 7 |
_a10.1172/JCI124607 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan de Veen, Willem | |
245 | 0 | 0 |
_aThe use of biologics for immune modulation in allergic disease. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _c03 2019 |
||
300 |
_a1452-1462 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAllergens _ximmunology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAsthma _xdrug therapy |
650 | 0 | 4 |
_aBiological Products _xtherapeutic use |
650 | 0 | 4 |
_aDermatitis, Atopic _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmune Tolerance _xdrug effects |
650 | 0 | 4 |
_aTh2 Cells _ximmunology |
700 | 1 | _aAkdis, Mübeccel | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 129 _gno. 4 _gp. 1452-1462 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI124607 _zAvailable from publisher's website |
999 |
_c29488233 _d29488233 |